Octagam® 5%, an Intravenous IgG Product, Is Efficacious and Well Tolerated in Subjects with Primary Immunodeficiency Diseases

Author: Ochs Hans D.   Pinciaro Paul J.    

Publisher: Springer Publishing Company

ISSN: 0271-9142

Source: Journal of Clinical Immunology, Vol.24, Iss.3, 2004-05, pp. : 309-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content